Sarah Yip, PhD, associate research scientist in the Yale Department of Psychiatry, has been awarded a place at the second annual Early Career Investigator Showcase co-sponsored by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
The symposium will be held November 11 during the NIDA-NIAAA Frontiers in Addiction Research Mini-Convention in San Diego. According to its website, the symposium “provides a forum for scientific presentations by premier young and junior investigators working in the fields of substance abuse and addiction research.”
Yip will present her work on “Neural moderators of galantamine treatment response in cocaine dependence.” The study, part of her K01 work on neural mechanisms of emerging medication treatments for addiction, aimed to determine whether neural responses at the start of treatment could predict treatment responses to galantamine versus placebo among individuals with cocaine dependence (n=65).
Study findings suggest that the efficacy of cholinergic enhancement treatment for cocaine dependence is moderated by striatal function, according to Yip.